2nd Quarter - Report

KOUNTOUPES DENHAM CARR & REID, LLC for CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION)

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the pharmaceutical supply chain, drug shortages and national stockpile issues, including H.R.2870, the Essential Medicines Strategic Stockpile Act of 2021. Issues related to supply chain provisions in S. 3799, PREVENT Pandemics Act. Issues related to pharmacy provider status. Issues related to the budget reconciliation process.

LobbyistCovered position, as disclosed
JULIE HERSHEY CARR —
LORI DENHAM —
CLAYTON PATRICK HAYES —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: S. 3799 (117th), H.R. 2870 (117th)

Pharmacy PHA

Issues related to proposals that would address drug shortages and national stockpile issues, including H.R. 2870, the Essential Medicines Strategic Stockpile Act of 2021. Issues related to COVID-19 vaccine distribution. Issues related to pharmacy provider status. Issues related to pharmaceutical supply chain provisions in S. 3799, PREVENT Pandemics Act. Issues related to the budget reconciliation process.

LobbyistCovered position, as disclosed
JULIE HERSHEY CARR —
LORI DENHAM —
CLAYTON PATRICK HAYES —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); SENATE

Bills named: H.R. 2870 (117th), S. 3799 (117th)

Defense DEF

Issues related to drug shortages and stockpile issues at the Department of Defense including H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023.

LobbyistCovered position, as disclosed
LORI DENHAM —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 7900 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.